1099 — Sinopharm Co Cashflow Statement
0.000.00%
- HK$54.77bn
- HK$138.11bn
- CNY575.17bn
Annual cashflow statement for Sinopharm Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 17,003 | 18,564 | 19,512 | 14,001 | 14,800 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 4,558 | 4,708 | 2,596 | 16,541 | 2,604 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -16,175 | -6,473 | -9,365 | -23,730 | -7,555 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 9,308 | 20,964 | 17,173 | 11,546 | 14,138 |
| Capital Expenditures | -2,256 | -2,418 | -2,336 | -1,968 | -1,617 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 989 | -1,172 | 1,391 | -1,783 | 653 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,267 | -3,590 | -945 | -3,751 | -964 |
| Financing Cash Flow Items | -5,997 | -6,274 | -5,471 | -4,635 | -3,667 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -14,693 | -5,693 | -7,644 | -17,285 | -18,687 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -6,649 | 11,692 | 8,587 | -9,495 | -5,517 |